71 related articles for article (PubMed ID: 8451795)
1. [Treatment of unknown primary tumor with cytostatic agents].
Hansen HH
Ugeskr Laeger; 1993 Feb; 155(8):567. PubMed ID: 8451795
[No Abstract] [Full Text] [Related]
2. Carcinoma of unknown primary origin: on the cusp of a new era.
Raber MN
Cancer J; 2010; 16(1):66-7. PubMed ID: 20164693
[No Abstract] [Full Text] [Related]
3. [Metastatic carcinoma of unknown origin].
Fizazi K; Culine S
Bull Cancer; 1998 Jul; 85(7):609-17. PubMed ID: 9752267
[TBL] [Abstract][Full Text] [Related]
4. Perspectives for targeted therapies in cancer of unknown primary site.
Pentheroudakis G; Pavlidis N
Cancer Treat Rev; 2006 Dec; 32(8):637-44. PubMed ID: 17046164
[TBL] [Abstract][Full Text] [Related]
5. 5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas of unknown primary site.
Culine S; Ychou M; Fabbro M; Romieu G; Cupissol D
Anticancer Res; 2001; 21(2B):1455-7. PubMed ID: 11396231
[TBL] [Abstract][Full Text] [Related]
6. Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?
Kourie HR; Awada G; Awada AH
Future Oncol; 2016 Feb; 12(4):429-31. PubMed ID: 26776661
[No Abstract] [Full Text] [Related]
7. Enlarged extraocular muscles from metastatic signet ring carcinoma.
Loes L; Wesley RE; Lavin P
Ophthalmic Surg Lasers; 1996 Jul; 27(7):632-5. PubMed ID: 9240782
[TBL] [Abstract][Full Text] [Related]
8. The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1999 Feb; 26(1 Suppl 2):129-33. PubMed ID: 10190795
[TBL] [Abstract][Full Text] [Related]
9. From gene testing to the bedside: workshop focuses on future strategies.
Goozner M
J Natl Cancer Inst; 2011 Aug; 103(15):1150-1. PubMed ID: 21768535
[No Abstract] [Full Text] [Related]
10. Management of peritoneal carcinomatosis of unknown primary tumor site.
Muggia FM; Baranda J
Semin Oncol; 1993 Jun; 20(3):268-72. PubMed ID: 8503022
[No Abstract] [Full Text] [Related]
11. Carcinoid tumour metastases to the maxilla.
Poon CC; Hasim F
Int J Oral Maxillofac Surg; 2007 Sep; 36(9):869-70. PubMed ID: 17521886
[No Abstract] [Full Text] [Related]
12. Cancer of unknown primary: what kind of chemotherapy? What kind of disease?
Pentheroudakis G; Pavlidis N
Onkologie; 2009 Apr; 32(4):159-60. PubMed ID: 19372709
[No Abstract] [Full Text] [Related]
13. Increased dosage of epirubicin and mitomycin-C for the treatment of metastatic adenocarcinoma of unknown primary site.
Polyzos A; Koulentianos E; Tzianoumis L; Sfikakis P
J Chemother; 1989 Jul; 1(4 Suppl):1185-6. PubMed ID: 16312826
[No Abstract] [Full Text] [Related]
14. Patients with unknown primaries face unusual insurance problems.
Reynolds T
J Natl Cancer Inst; 1998 Feb; 90(4):269. PubMed ID: 9486810
[No Abstract] [Full Text] [Related]
15. Genetics: CUP: discovering genetic opportunities.
Hutchinson L
Nat Rev Clin Oncol; 2015 May; 12(5):251. PubMed ID: 25781575
[No Abstract] [Full Text] [Related]
16. One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site.
Greco FA; Hainsworth JD
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-101-S19-105. PubMed ID: 9427278
[TBL] [Abstract][Full Text] [Related]
17. Metastatic rhabdomyosarcoma of the skin.
Shimizu S; Yasui C; Minauchi K; Tsuchiya K
J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S118-20. PubMed ID: 18489044
[No Abstract] [Full Text] [Related]
18. Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site.
Sève P; Reiman T; Lai R; Hanson J; Santos C; Johnson L; Dabbagh L; Sawyer M; Dumontet C; Mackey JR
Cancer Chemother Pharmacol; 2007 Jun; 60(1):27-34. PubMed ID: 17021819
[TBL] [Abstract][Full Text] [Related]
19. Forty years experience of treating cancer of unknown primary.
Pavlidis N
Acta Oncol; 2007; 46(5):592-601. PubMed ID: 17562435
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous adenocarcinoma metastases associated with swelling of the neck and cheeks.
Yasukawa K; Shimizu S; Yasui C; Sawamura D; Tsuchiya K
Acta Derm Venereol; 2004; 84(5):399-400. PubMed ID: 15503358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
